Prediction of Postoperative Recurrence-Free Survival in Non-Small Cell Lung Cancer by Using an Internationally Validated Gene Expression Model

  • Mitra, Ranjana; 
  • Lee, Jinseon; 
  • Jo, Jisuk; 
  • Milani, Monica; 
  • McClintick, Jeanette N.; 
  • 외 17명
Citations

WEB OF SCIENCE

42
Citations

SCOPUS

43

초록

Purpose: This study was performed to discover prognostic genomic markers associated with postoperative outcome of stage I to III non-small cell lung cancer (NSCLC) that are reproducible between geographically distant and demographically distinct patient populations. Experimental Design: American patients (n = 27) were stratified on the basis of recurrence and microarray profiling of their tumors was performed to derive a training set of 44 genes. A larger Korean patient validation cohort (n = 138) was also stratified by recurrence and screened for these genes. Four reproducible genes were identified and used to construct genomic and clinicogenomic Cox models for both cohorts. Results: Four genomic markers, DBN1 (drebrin 1), CACNB3 (calcium channel beta 3), FLAD1 (PP591; flavin adenine dinucleotide synthetase), and CCND2 (cyclin D2), exhibited highly significant differential expression in recurrent tumors in the training set (P < 0.001). In the validation set, DBN1, FLAD1 (PP591), and CACNB3 were significant by Cox univariate analysis (P <= 0.035), whereas only DBN1 was significant by multivariate analysis. Genomic and clinicogenomic models for recurrence-free survival (RFS) were equally effective for risk stratification of stage I to II or I to III patients (all models P < 0.0001). For stage I to II or I to III patients, 5-year RFS of the low-and high-risk patients was approximately 70% versus 30% for both models. The genomic model for overall survival of stage I to III patients was improved by addition of pT and pN stage (P < 0.0013 vs. 0.010). Conclusion: A 4-gene prognostic model incorporating the multivariate marker DBN1 exhibits potential clinical utility for risk stratification of stage I to III NSCLC patients. Clin Cancer Res; 17(9); 2934-46. (C) 2011 AACR.

키워드

PROGNOSIS; SIGNATURE; IMPACT
제목
Prediction of Postoperative Recurrence-Free Survival in Non-Small Cell Lung Cancer by Using an Internationally Validated Gene Expression Model
저자
Mitra, Ranjana; Lee, Jinseon; Jo, Jisuk; Milani, Monica; McClintick, Jeanette N.; Edenberg, Howard J.; Kesler, Kenneth A.; Rieger, Karen M.; Badve, Sunil; Cummings, Oscar W.; Mohiuddin, Ahmed; Thomas, Dafydd G.; Luo, Xianghua; Juliar, Beth E.; Li, Lang; Mesaros, Clementina; Blair, Ian A.; Srirangam, Anjaiah; Kratzke, Robert A.; McDonald, Clement J.; Kim, Jhingook; Potter, David A.
DOI
10.1158/1078-0432.CCR-10-1803
발행일
2011-05-01
유형
Article
저널명
Clinical Cancer Research
권
17
호
9
페이지
2934 ~ 2946